|
Status |
Public on Feb 04, 2013 |
Title |
Normal prostate NP_331 |
Sample type |
genomic |
|
|
Source name |
Normal Prostate
|
Organism |
Homo sapiens |
Characteristics |
tissue site: Prostate tissue type: Normal sample id (short form for plotting): NP_331 description: Normal prostate
|
Treatment protocol |
For MBD-SNP, samples were enriched for methylated DNA using magnetic-bead immobilized methyl-binding domain polypeptides as described previously (Yegnasubramanian et al., Nucl Acids Res, 2006; Yegnasubramanian et al., BMC Genomics, 2011). A unenriched total input sample that was otherwise treated the same, was used as a reference for each sample and was used to derive copy number estimates.
|
Growth protocol |
DNA was obtained from metastatic prostate cancer tissues from the PELICAN rapid autopsy program at Johns Hopkins University, and from normal prostate tissues from organ donors.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was extracted using the manufacturer's recommended protocol
|
Label |
Cy3 and Cy5
|
Label protocol |
Standard Illumina protocol for Human Methylation450k DNA Analysis bead chip
|
|
|
Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridised to the Illumina Infinium Human Methylation450k Beadchip using the standard Illumina protocol
|
Scan protocol |
Arrays were imaged using a BeadArray Reader
|
Data processing |
Data was normalized using the 'minfi' R package (Scale normalization, No background subtraction).
|
|
|
Submission date |
May 25, 2012 |
Last update date |
Feb 04, 2013 |
Contact name |
Martin Aryee |
E-mail(s) |
aryee.martin@mgh.harvard.edu
|
Organization name |
Massachusetts General Hospital
|
Department |
Pathology
|
Street address |
149 13th Street
|
City |
Charlestown |
State/province |
MA |
ZIP/Postal code |
02129 |
Country |
USA |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE38240 |
DNA methylation profiling of normal prostates and prostate cancer metastases [Illumina] |
GSE38242 |
DNA methylation alterations exhibit striking intra-individual stability and inter-individual heterogeneity across metastatic dissemination |
|